全球核酸標記市場規模（按產品、技術、應用、地區、範圍和預測）

核酸標記的市場規模及預測

核酸標記市場規模預計在 2023 年達到 18.7 億美元，到 2030 年將達到 47.5 億美元，2024 年至 2030 年的複合年增長率為 9.7%。

核酸標記市場的全球市場推動因素

核酸標記市場的市場推動因素會受到多種因素的影響。

分子生物學研究進展：

主要驅動力之一是遺傳學和分子生物學的不斷發展。核酸標記對於基因表現分析、RNA定序和DNA定序等技術至關重要，從而推動了對該產品的需求。

擴大診斷應用：

隨著核酸標記在 PCR（聚合酶鍊式反應）、微陣列和原位雜交等診斷過程中的應用越來越多，市場也不斷成長。這些方法對於識別許多疾病至關重要，包括癌症和傳染病。

個人化醫療的需求日益增長：

個人化醫療的發展推動了核酸標記的需求，個人化醫療需要準確、精確的基因數據。對更有針對性的治療和改善患者治療效果的需求是這種發展的原因。

增加政府支持與資金：

得益於政府對蛋白質體學和基因組學研究的計畫和資助，核酸標記產業正在不斷擴大。生命科學研究的進步極大地得益於公共部門的資助。

創新：

透過標記程序的不斷創新，包括創建新的螢光和放射性標記，核酸標記的效率和準確性正在提高。這些發展透過提高實驗室和診斷設備的功能正在擴大市場。

擴大生物製藥領域：

瞭解新藥的效果和作用機制需要瞭解標籤技術。

遺傳疾病發生率不斷上升：

由於遺傳疾病的盛行率不斷上升以及相關的基因檢測和研究需求，核酸標記市場正在不斷增長。準確的標記對於識別基因改變和瞭解此類突變的後果至關重要。

限制全球核酸標記市場的因素

有幾個因素可能會對核酸標記市場造成限制和課題。

標記試劑盒和試劑成本高：

對於預算緊張的小型實驗室或學術機構來說，核酸標記試劑盒和試劑的高成本可能是一個主要障礙。

技術困難與複雜性：

核酸標記程序技術性很強且複雜，需要特定的知識和工具。它的複雜性可能會阻礙採用，特別是在基礎設施或經驗有限的環境中。

監理與道德問題：

圍繞基因工程和研究的嚴格規定和道德問題可能會帶來問題。克服這些規定所需的時間和費用可能會影響市場擴張。

認知與採用有限：

在某些地區，先進的核酸標記技術可能較不為人所知，也未廣泛應用。這可能是由於缺乏教育、培訓或無法獲得現代研究方法和設備。

與替代技術的衝突：

用於標記和偵測商品的替代技術對市場構成競爭威脅。這些替代技術的發展可能會減少對傳統核酸標記產品的需求。

智慧財產權問題：

有關專利和智慧財產權的問題也可能構成障礙。公司在使用某些標籤技術時可能會遇到法律課題或限制，這可能會阻礙市場成長和創新。

供應鏈中斷：

核酸標記所需試劑和原料供應鏈的延遲可能會對市場產生不利影響。這可能是由於自然災害、地緣政治動盪或其他意外事件造成的。

新興市場飽和：

在市場已經飽和的新興國家，市場發展可能受到限制。公司必須關注新興市場，因為新興市場也可能帶來課題和不確定性。

目錄

第 1 章全球核酸標記市場：簡介

市場概況
• 研究範圍
• 先決條件

第 2 章執行摘要

第 3 章：經過驗證的市場研究方法

• 資料探勘
• 驗證
• 主要來源
• 資料來源列表

第四章 全球核酸標記市場展望

• 概述
• 市場動態
  • 驅動程式
  • 阻礙因素
  • 機會
• 波特五力模型
• 價值鏈分析
• 監理框架

第 5 章。

• 概述
• 試劑
• 套件
• 服務

6. 全球核酸標記市場（依技術）

• 概述
• PCR 方法
• 尼克翻譯
• 隨機引物 體外轉錄
• 逆轉錄
• 結束標記

第 7 章全球核酸標記市場（依應用）

• 概述 DNA定序
• 聚合酶鍊式反應
• 螢光原位雜交（FISH）
• 微陣列 印跡 原位雜交
• 其他用途

第 8 章全球核酸標記市場（按地區）

• 概述
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 法國
  • 其他歐洲國家
  亞太地區
  • 中國
  • 日本
  • 印度
  • 其他亞太地區
• 世界其他地區
  • 拉丁美洲
  • 中東和非洲

第九章全球核酸標記市場的競爭格局

• 概述
• 公司市佔率
• 供應商概況
• 主要發展策略

第十章 公司簡介

• Agilent Technologies, Inc.
• Enzo Biochem, Inc.
• F. Hoffman-La Roche AG
• General Electric Company
• Merck KGaA（Germany）
• New England Biolabs
• Perkinelmer, Inc.
• Promega Corporation
• Thermo Fisher Scientific, Inc.
• Vector Laboratories

第 11 章附錄

• 相關研究

Nucleic Acid Labeling Market Size And Forecast

Nucleic Acid Labeling Market size was valued at USD 1.87 Billion in 2023 and is projected to reach USD 4.75 Billion by 2030 , growing at a CAGR of 9.7% from 2024 to 2030. Global Nucleic Acid Labeling Market Drivers The market drivers for the Nucleic Acid Labeling Market can be influenced by various factors. These may include:

Research Advancements in Molecular Biology:

One of the main drivers is the ongoing development of genetic and molecular biology. Nucleic acid labeling is crucial to methods like gene expression analysis, RNA sequencing, and DNA sequencing, which drives up demand for the product.

Growing Applications in Diagnostics:

The market is growing as a result of the growing use of nucleic acid labeling in diagnostic processes such PCR (Polymerase Chain Reaction), microarrays, and in situ hybridization. These methods are essential for identifying a number of illnesses, such as cancer and infectious infections.

Growing Need for Personalized Medicine:

The need for nucleic acid labeling is being driven by the movement toward personalized medicine, which necessitates precise and accurate genetic data. The demand for more focused treatments and better patient outcomes is what is causing this development.

Increase in Government Support and Funding:

The nucleic acid labeling industry is expanding thanks to government programs and funding for proteomics and genomics research. The advancement of life sciences research is greatly aided by public sector funding.

Technological Innovations:

The efficiency and precision of labeling nucleic acids are improved by continuous technological breakthroughs in labeling procedures, such as the creation of new fluorescent and radioactive labels. Because these developments enhance the capacities of research and diagnostic instruments, the market is expanding.

Extension of the Biopharmaceutical Sector:

Another important driver is the biopharmaceutical sector's expansion, which depends on nucleic acid labeling for drug research and development procedures. grasp the effects and mechanisms of action of novel medications requires a grasp of labeling techniques.

Increased Prevalence of Genetic illnesses:

The market for nucleic acid labeling is seeing growth because to the increased prevalence of genetic illnesses and the resulting need for genetic testing and research. To identify genetic alterations and comprehend the consequences of such mutations, accurate labeling is essential.

Global Nucleic Acid Labeling Market Restraints

Several factors can act as restraints or challenges for the Nucleic Acid Labeling Market. These may include:

High Costs of Labeling Kits and Reagents:

For smaller research labs and academic institutions with tighter budgets, the high costs of labeling kits and reagents for nucleic acids can be a major obstacle.

Technical Difficulties and Complexity:

Nucleic acid labeling procedures can be highly technical and complex, requiring specific knowledge and tools. Adoption may be hampered by its complexity, especially in environments with inadequate infrastructure and experience.

Regulatory and Ethical Issues:

Tight regulations and moral issues pertaining to genetic engineering and research might be problematic. The expansion of the market may be impacted by the time and money required to navigate these rules.

Limited Awareness and Adoption:

Advanced nucleic acid labeling technologies may not be as well known or used as they could be in some areas. Lack of education, training, or access to the newest methods and instruments for study could be the cause of this.

Competition from Alternative Technologies:

Alternative technologies for marking and detecting goods are a competitive threat to the market. Developments in these substitute techniques may lessen the need for conventional nucleic acid labeling products.

Intellectual Property Problems:

Problems with patents and rights to intellectual property can also serve as barriers. Businesses may encounter legal issues or limitations when utilizing specific labeling technology, which can stifle market growth and innovation.

Disruptions to the Supply Chain:

The market may suffer if there are any delays in the supply chain for the reagents and raw materials needed for nucleic acid labeling. Natural catastrophes, geopolitical unrest, or other unanticipated events may be to blame for this.

Market Saturation in Developed Regions:

Growth prospects may be restricted in developed regions where the market is already saturated. Businesses could have to concentrate on developing markets, which can present unique difficulties and uncertainties of their own.

Global Nucleic Acid Labeling Market Segmentation Analysis

The Global Nucleic Acid Labeling Market is Segmented on the basis of Product, Technique, Application, And Geography.

Nucleic Acid Labeling Market, By Product

• Reagents and Kits:
• This segment includes various reagents and kits used for labeling nucleic acids, such as labeling reagents, probes and labels, enzymes, and others.
• Services:
• This segment comprises services related to nucleic acid labeling, including customization, consulting, and others.

Nucleic Acid Labeling Market, By Technique

• Radioactive Labeling:
• This technique involves the use of radioactive isotopes to label nucleic acids for various applications.
• Non-radioactive Labeling:
• This technique uses non-radioactive methods, such as fluorescent labeling, biotin-based labeling, and others, to label nucleic acids.

Nucleic Acid Labeling Market, By Application

• Microarray:
• Nucleic acid labeling is used in microarray technology for gene expression profiling and other genomic applications.
• Sequencing:
• Labeling is crucial in nucleic acid sequencing methods to identify and analyze nucleotide sequences.
• PCR: Polymerase chain reaction (PCR) applications often require nucleic acid labeling for amplification and detection purposes.
• FISH (Fluorescent In Situ Hybridization):
• FISH uses fluorescently labeled probes to detect and localize specific DNA sequences on chromosomes.
• In Situ Hybridization:
• In this technique, labeled nucleic acid probes are used to detect complementary DNA or RNA sequences in cells or tissues.
• Other Applications
• : This includes various other applications of nucleic acid labeling in research, diagnostics, and other fields.

Nucleic Acid Labeling Market, By Geography

• North America:
• This region includes the U.S. and Canada, which are major markets for nucleic acid labeling products and services.
• Europe
• : The European market comprises countries like the U.K., Germany, France, and others, where there is a significant demand for nucleic acid labeling.
• Asia Pacific:
• Countries like China, Japan, India, and others in the Asia Pacific region are witnessing growth in the nucleic acid labeling market.
• Latin America:
• Brazil, Mexico, and other Latin American countries contribute to the nucleic acid labeling market in this region.
• Middle East & Africa:
• The market in this region includes countries in the GCC, South Africa, and others, where nucleic acid labeling is used in various applications.

Key Players

• The major players in the Nucleic Acid Labeling Market are:
• Agilent Technologies, Inc.
• Enzo Biochem, Inc.
• F. Hoffman-La Roche AG
• General Electric Company
• Merck KGaA (Germany)
• New England Biolabs
• Perkinelmer, Inc.
• Promega Corporation
• Thermo Fisher Scientific, Inc.
• Vector Laboratories

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL NUCLEIC ACID LABELING MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL NUCLEIC ACID LABELING MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis
• 4.5 Regulatory Framework

5 GLOBAL NUCLEIC ACID LABELING MARKET, BY PRODUCT

• 5.1 Overview
• 5.2 Reagents
• 5.3 Kits
• 5.4 Services

6 GLOBAL NUCLEIC ACID LABELING MARKET, BY TECHNIQUE

• 6.1 Overview
• 6.2 PCR
• 6.3 Nick Translation
• 6.4 Random Primer
• 6.5 In Vitro Transcription
• 6.6 Reverse Transcription
• 6.7 End Labeling

7 GLOBAL NUCLEIC ACID LABELING MARKET, BY APPLICATION

• 7.1 Overview
• 7.2 DNA Sequencing
• 7.3 Polymerase Chain Reaction
• 7.4 Fluorescence in Situ Hybridization (FISH)
• 7.5 Microarrays
• 7.6 Blotting
• 7.7 in Situ Hybridization
• 7.8 Other Applications

8 GLOBAL NUCLEIC ACID LABELING MARKET, BY GEOGRAPHY

• 8.1 Overview
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 U.K.
  • 8.3.3 France
  • 8.3.4 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Rest of the World
  • 8.5.1 Latin America
  • 8.5.2 Middle East and Africa

9 GLOBAL NUCLEIC ACID LABELING MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market Share
• 9.3 Vendor Landscape
• 9.4 Key Development Strategies

10 COMPANY PROFILES

• 10.1 Agilent Technologies, Inc.
  • 10.1.1 Overview
  • 10.1.2 Financial Performance
  • 10.1.3 Product Outlook
  • 10.1.4 Key Developments
• 10.2 Enzo Biochem, Inc.
  • 10.2.1 Overview
  • 10.2.2 Financial Performance
  • 10.2.3 Product Outlook
  • 10.2.4 Key Developments
• 10.3 F. Hoffman-La Roche AG
  • 10.3.1 Overview
  • 10.3.2 Financial Performance
  • 10.3.3 Product Outlook
  • 10.3.4 Key Developments
• 10.4 General Electric Company
  • 10.4.1 Overview
  • 10.4.2 Financial Performance
  • 10.4.3 Product Outlook
  • 10.4.4 Key Developments
• 10.5 Merck KGaA (Germany)
  • 10.5.1 Overview
  • 10.5.2 Financial Performance
  • 10.5.3 Product Outlook
  • 10.5.4 Key Developments
• 10.6 New England Biolabs
  • 10.6.1 Overview
  • 10.6.2 Financial Performance
  • 10.6.3 Product Outlook
  • 10.6.4 Key Developments
• 10.7 Perkinelmer, Inc.
  • 10.7.1 Overview
  • 10.7.2 Financial Performance
  • 10.7.3 Product Outlook
  • 10.7.4 Key Developments
• 10.8 Promega Corporation
  • 10.8.1 Overview
  • 10.8.2 Financial Performance
  • 10.8.3 Product Outlook
  • 10.8.4 Key Developments
• 10.9 Thermo Fisher Scientific, Inc.
  • 10.9.1 Overview
  • 10.9.2 Financial Performance
  • 10.9.3 Product Outlook
  • 10.9.4 Key Developments
• 10.10 Vector Laboratories
  • 10.10.1 Overview
  • 10.10.2 Financial Performance
  • 10.10.3 Product Outlook
  • 10.10.4 Key Developments

11 Appendix

• 11.1 Related Research